Skip to main content
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
23.21
-0.35 (-1.49%)
Apr 29, 2026, 11:38 AM EDT - Market open

Legend Biotech Revenue

In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth. Legend Biotech had revenue of $306.38M in the quarter ending December 31, 2025, with 64.21% growth.

Revenue (ttm)
$1.03B
Revenue Growth
+64.02%
P/S Ratio
4.21
Revenue / Employee
$347,015
Employees
2,965
Market Cap
4.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 2020 Pro Pro Pro
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ACADIA Pharmaceuticals 1.07B
Corcept Therapeutics 761.41M
Amicus Therapeutics 634.21M
Travere Therapeutics 490.73M
Ligand Pharmaceuticals 268.09M
Tango Therapeutics 62.38M
Crinetics Pharmaceuticals 7.70M
CRISPR Therapeutics AG 3.51M
Revenue Rankings

LEGN News

More News